Shinichiro Takahashi

机构：Tokai University, National Cancer Center Hospital East · ORCID：0000-0002-4828-3965

发表论文 522 篇 · 总被引 8340 次 · h-index 46

代表论文

• Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis (2020 · Advanced Science · 被引 108)
• Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer (2025 · Annals of Surgery · 被引 95)
• Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems (2020 · Scientific Reports · 被引 55)
• Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases (2021 · Annals of Surgical Oncology · 被引 44)
• Randomized phase II trial of chemoradiotherapy with S‐1 versus combination chemotherapy with gemcitabine and S‐1 as neoadjuvant treatment for resectable pancreatic cancer ( JASPAC 04) (2023 · Journal of Hepato-Biliary-Pancreatic Sciences · 被引 32)
• Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses (2021 · International Journal of Cancer · 被引 32)